EUVIMEDEUVIMED entdecken
Kommentar

Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?

Antonis Fanouriakis, Y K Onno Teng

Kidney International · 2026-07 · 110 (1) · 39-41

DOI: 10.1016/j.kint.2026.04.005 ↗

Kurz gefasst

Kommentar in der Zeitschrift Kidney International, 2026-07. Verfasst von Antonis Fanouriakis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology and Clinical Immunology Unit, "Attikon" University Hospital, Medical School National and Kapodistrian University of Athens, Athens, Gree…. Hauptthemen laut MEDLINE: Lupus Nephritis, Immunosuppressive Agents, Antibodies, Antinuclear, Watchful Waiting. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lupus nephritis flares are occasionally preceded by a rise in serologic activity. To date, watchful waiting is the suggested approach for patients with such a serologic reactivation. Yap et al. performed a randomized trial testing a pre-emptive increase in immunosuppression versus watchful monitoring in patients with stable lupus nephritis who had a rise in their anti-double-stranded DNA antibodies. We discuss their results in the context of the current landscape and expanding therapeutic options for the management of lupus nephritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisImmunosuppressive AgentsAntibodies, AntinuclearWatchful WaitingHumansRemission InductionAsymptomatic DiseasesTreatment Outcome

Substanzen

Immunosuppressive AgentsAntibodies, Antinuclearanti-dsDNA autoantibody

Autor:innen und Institutionen

  • Rheumatology and Clinical Immunology Unit, "Attikon" University Hospital, Medical School National and Kapodistrian University of Athens, Athens, Greece. Electronic address: afanour@med.uoa.gr.
  • Center of Expertise for Lupus, Vasculitis and Complement-Mediated Systemic Diseases, Department of Internal Medicine-Section Nephrology, Leiden University Medical Center, Leiden, the Netherlands.

Zitieren

APA

Fanouriakis, A., & Teng, Y. K. O. (2026). Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?. Kidney International, 110(1), 39-41. https://doi.org/10.1016/j.kint.2026.04.005

Vancouver

Fanouriakis A, Teng YKO. Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?. Kidney International. 2026;110(1):39-41. doi:10.1016/j.kint.2026.04.005

BibTeX
@article{Fanouriakis2026,
  author = {Fanouriakis, Antonis and Teng, Y K Onno},
  title = {Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?},
  journal = {Kidney International},
  year = {2026},
  volume = {110},
  number = {1},
  pages = {39--41},
  doi = {10.1016/j.kint.2026.04.005}
}
Kostenlos starten →